Lipella Pharmaceuticals Inc. (LIPO) Operating income 2021–2024
Lipella Pharmaceuticals Inc. (LIPO) annual operating income history from SEC filings — each fiscal year as reported.
-$5.1MFY2024 · since FY2021: -$1.9M → -$5.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$5.1M | -7.0% |
| FY2023 | -$4.7M | -83.3% |
| FY2022 | -$2.6M | -35.2% |
| FY2021 | -$1.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice